Cytokinetics reported $1.15M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.47M 15.29M
Acorda Therapeutics ACOR:US $ 22.53M 14.43M
Amgen AMGN:US $ 6238M 608M
Bayer BAYN:GR € 14639M 3521M
Biogen BIIB:US $ 2531.8M 202M
Bristol Myers Squibb BMY:US $ 11648M 337M
Capricor Therapeutics CAPR:US $ 0M 0M
Cytokinetics CYTK:US $ 1.15M 54.45M
Eisai 4523:JP Y 190901M 12071M
Eli Lilly And LLY:US $ 7810M 189.9M
Exelixis EXEL:US $ 355.98M 95.16M
Genocea Biosciences GNCA:US $ 0.27M 0.27M
Geron GERN:US $ 0.12M 0.92M
Halozyme Therapeutics HALO:US $ 117.28M 15.28M
Intra Cellular Therapies ITCI:US $ 35M 9.32M
Ligand Pharmaceuticals LGND:US $ 45.69M 26.78M
Merk MRK:US $ 15901M 2380M
Novartis NOVN:VX SF 12814M 708M
Pfizer PFE:US $ 25661M 2026M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Roche Holding ROG:VX 16.44B 474M